BioTech Health Information Pharmaceuticals Primary Care 
Healthcare IT Today
JANUARY 8, 2024
It is key for pharmaceutical companies to recognize that efficiency does not override compliance, patient safety or regulatory standards. Health Economics Outcomes Research (HEOR) will become more common in decentralized clinical trials (DCTs). Dave Latshaw, CEO at BioPhy 1.
Lloyd Price
SEPTEMBER 2, 2023
This growth is expected to create opportunities for M&A activity, as pharmaceutical companies look to acquire smaller, innovative biotech companies. This trend is expected to continue in 2023, particularly in the areas of primary care, diagnostics, and hospital services.
Expert insights. Personalized for you.
87 
Let's personalize your content